Wasatch Advisors LP Trims Holdings in Addus HomeCare Co. (NASDAQ:ADUS)

Wasatch Advisors LP reduced its stake in Addus HomeCare Co. (NASDAQ:ADUS) by 0.5% in the 4th quarter, Holdings Channel reports. The institutional investor owned 1,038,489 shares of the company’s stock after selling 4,751 shares during the period. Wasatch Advisors LP owned 0.06% of Addus HomeCare worth $130,175,000 at the end of the most recent quarter.

Several other institutional investors have also modified their holdings of ADUS. State Street Corp boosted its holdings in Addus HomeCare by 4.4% in the 3rd quarter. State Street Corp now owns 663,610 shares of the company’s stock valued at $88,280,000 after purchasing an additional 27,990 shares during the last quarter. Barclays PLC lifted its holdings in Addus HomeCare by 204.8% in the third quarter. Barclays PLC now owns 43,470 shares of the company’s stock valued at $5,783,000 after acquiring an additional 29,207 shares during the last quarter. Geode Capital Management LLC grew its position in Addus HomeCare by 7.1% in the third quarter. Geode Capital Management LLC now owns 423,934 shares of the company’s stock worth $56,406,000 after acquiring an additional 28,284 shares during the period. Franklin Resources Inc. raised its position in Addus HomeCare by 2.7% in the third quarter. Franklin Resources Inc. now owns 26,216 shares of the company’s stock valued at $3,456,000 after purchasing an additional 701 shares during the period. Finally, Principal Financial Group Inc. lifted its stake in shares of Addus HomeCare by 17.5% in the 3rd quarter. Principal Financial Group Inc. now owns 505,853 shares of the company’s stock valued at $67,293,000 after purchasing an additional 75,409 shares during the last quarter. Hedge funds and other institutional investors own 95.35% of the company’s stock.

Addus HomeCare Trading Down 2.9 %

NASDAQ:ADUS opened at $99.24 on Wednesday. Addus HomeCare Co. has a 12-month low of $87.88 and a 12-month high of $136.72. The firm has a market cap of $1.80 billion, a PE ratio of 22.71, a price-to-earnings-growth ratio of 1.41 and a beta of 0.93. The stock has a fifty day moving average price of $100.32 and a 200 day moving average price of $117.64.

Addus HomeCare (NASDAQ:ADUS) last announced its quarterly earnings data on Monday, February 24th. The company reported $1.26 EPS for the quarter, missing analysts’ consensus estimates of $1.35 by ($0.09). The company had revenue of $297.14 million for the quarter, compared to analyst estimates of $291.04 million. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. Equities analysts forecast that Addus HomeCare Co. will post 4.59 EPS for the current year.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on ADUS. Macquarie restated an “outperform” rating and issued a $129.00 price objective on shares of Addus HomeCare in a report on Thursday, February 27th. StockNews.com downgraded shares of Addus HomeCare from a “buy” rating to a “hold” rating in a research note on Wednesday, February 26th. Stephens reaffirmed an “overweight” rating and set a $142.00 price objective on shares of Addus HomeCare in a research report on Wednesday, March 12th. Oppenheimer boosted their target price on Addus HomeCare from $145.00 to $150.00 and gave the company an “outperform” rating in a research report on Friday, January 24th. Finally, JMP Securities restated a “market outperform” rating and set a $150.00 price target on shares of Addus HomeCare in a research report on Thursday, April 10th. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating, seven have assigned a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat, Addus HomeCare currently has an average rating of “Moderate Buy” and a consensus price target of $132.78.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.